PENFOLD PHILIP LESLIE,PEYMAN GHOLAM ALI,SANDERS DONALD ROBERT,PENFOLD Philip Leslie,PEYMAN Gholam Ali,SANDERS Donald Robert
申请号：
SI200531800
公开号：
SI1755616T1
申请日:
2005.04.08
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention provides a method of treatment of an individual with an ophthalmic condition that may comprise the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound may be an anti-oedematous steroid, more preferably a mineralocorticoid.
